Nora Pashayan

10.0k total citations
104 papers, 2.1k citations indexed

About

Nora Pashayan is a scholar working on Oncology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Nora Pashayan has authored 104 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Oncology, 36 papers in Genetics and 20 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Nora Pashayan's work include Global Cancer Incidence and Screening (41 papers), BRCA gene mutations in cancer (32 papers) and Colorectal Cancer Screening and Detection (20 papers). Nora Pashayan is often cited by papers focused on Global Cancer Incidence and Screening (41 papers), BRCA gene mutations in cancer (32 papers) and Colorectal Cancer Screening and Detection (20 papers). Nora Pashayan collaborates with scholars based in United Kingdom, United States and Canada. Nora Pashayan's co-authors include Paul D.P. Pharoah, Stephen Morris, Susmita Chowdhury, Tom Dent, Fiona J. Gilbert, Alison Hall, Rosalind A. Eeles, David E. Neal, Geordan Shannon and H. Burton and has published in prestigious journals such as Science, Nature Communications and Nature Genetics.

In The Last Decade

Nora Pashayan

99 papers receiving 2.0k citations

Peers

Nora Pashayan
Comparison fields: 5 of 128
  • Oncology 811
  • Genetics 654
  • Pulmonary and Respiratory Medicine 384
  • Public Health, Environmental and Occupational Health 262
  • Economics and Econometrics 212
Sherri L. Stewart United States
Stephanie V. Blank United States
Susan Dent Canada
Amyé Tevaarwerk United States
Mina S. Sedrak United States
Nagi S. El Saghir Lebanon
Elissa Bantug United States
Yanin Chávarri-Guerra Mexico
Margaret Kemeny United States
Cynthia Villarreal‐Garza Mexico
Sherri L. Stewart United States View profile →
Citations per field, relative to Nora Pashayan
Nora Pashayan · 1×
Citations per year, relative to Nora Pashayan
Nora Pashayan · 1×

Countries citing papers authored by Nora Pashayan

Since Specialization
Citations

This map shows the geographic impact of Nora Pashayan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nora Pashayan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nora Pashayan more than expected).

Fields of papers citing papers by Nora Pashayan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nora Pashayan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nora Pashayan. The network helps show where Nora Pashayan may publish in the future.

Co-authorship network of co-authors of Nora Pashayan

This figure shows the co-authorship network connecting the top 25 collaborators of Nora Pashayan. A scholar is included among the top collaborators of Nora Pashayan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nora Pashayan. Nora Pashayan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 Systems epigenetic approach towards non-invasive breast cancer detection Nature Communications Chiara Herzog, Allison Jones et al. 3
2 Growth kinetics of high-grade serous ovarian cancer: implications for early detection British Journal of Cancer Mitul Shah, Susan Freeman et al. 1
3 Screening for multiple cancers: evaluation must go beyond aggregate measures BMJ Thomas Callender, Katherine Payne et al. 1
4 Estimation of age of onset and progression of breast cancer by absolute risk dependent on polygenic risk score and other risk factors Cancer Ardo van den Hout, Antonis C. Antoniou et al. 7
5 Cancer incidence and competing mortality risk following 15 presenting symptoms in primary care: a population-based cohort study using electronic healthcare records SHILAP Revista de lepidopterología Matthew Barclay, Cristina Renzi et al. 1
6 Risk stratification in breast screening workshop BMC Proceedings A. W. Anderson, Cristina Visintin et al. 1
7 DNA methylation at quantitative trait loci (mQTLs) varies with cell type and nonheritable factors and may improve breast cancer risk assessment npj Precision Oncology Chiara Herzog, Allison Jones et al. 2
8 Prevalence of MRI lesions in men responding to a GP-led invitation for a prostate health check: a prospective cohort study SHILAP Revista de lepidopterología Caroline M. Moore, Eleni Frangou et al. 23
9 Risk-stratified breast cancer screening incorporating a polygenic risk score: a survey of UK GPs’ knowledge and attitudes British Journal of General Practice Julie Lapointe, Hermann Nabi et al. 1
10 Potential of polygenic risk scores for improving population estimates of women’s breast cancer genetic risks Genetics in Medicine Michael Wolfson, Steven D. Gribble et al. 13
11 A Systematic Review on Cost-effectiveness Studies Evaluating Ovarian Cancer Early Detection and Prevention Strategies Cancer Prevention Research Gaby Sroczynski, Martin Widschwendter et al. 12
12 Runs of homozygosity and testicular cancer risk Andrology Chey Loveday, Amit Sud et al. 4
13 Polygenic risk-tailored screening for prostate cancer: A benefit–harm and cost-effectiveness modelling study PLoS Medicine Thomas Callender, Mark Emberton et al. 48
14 Prediction models for endometrial cancer for the general population or symptomatic women: A systematic review Critical Reviews in Oncology/Hematology Kimberley Velt, Nora Pashayan et al. 25
15 Do Health Professionals Need Additional Competencies for Stratified Cancer Prevention Based on Genetic Risk Profiling? Journal of Personalized Medicine Susmita Chowdhury, Lidewij Henneman et al. 13
16 Implications of polygenic risk-stratified screening for prostate cancer on overdiagnosis Genetics in Medicine Nora Pashayan, Stephen Duffy et al. 69
17 Adjusting the frequency of mammography screening on the basis of genetic risk: Attitudes among women in the UK The Breast Susanne F. Meisel, Nora Pashayan et al. 51
18 Public health implications of personalised screening for cancer: The First Collaborative Oncological Gene-environment Study (COGS) Workshop findings UCL Discovery (University College London) Nora Pashayan, Andy Hall et al. 2
19 Measuring health: A practical challenge with a philosophical solution? Maturitas Amir Shroufi, Rajiv Chowdhury et al. 6
20 Excess cases of prostate cancer and estimated overdiagnosis associated with PSA testing in East Anglia British Journal of Cancer Nora Pashayan, John Powles et al. 32

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026